HALIFAX, NS, June 25, 2020
Adaptiiv Medical Technologies Inc. (Adaptiiv) is proud to announce it has been named the first-ever recipient of Atlantic Canada’s Health Challenge focusing on cancer care.
The company was recently awarded the prestigious prize as determined by a panel of judges comprised of experts in the sectors of healthcare, technology, and government.
This undertaking will see full deployment of Adaptiiv’s innovative technology into the Nova Scotia Health Authority’s (NSHA) clinical workflow with the goal of improving traditional processes and maximizing efficiencies.
“Working with Adaptiiv will allow the NSHA to further implement innovative technologies that improve the accuracy and level of care that is required of our medical practitioners in order to make concise, life-saving treatments for patients in Atlantic Canada,” says Dr. Gail Tomblin Murphy, Vice President of Research, Innovation & Discovery and CNE at NSHA.
Adaptiiv’s primary focus is to improve treatment accuracy and patient care by combining its software platform and 3D printing to design and create patient-specific radiotherapy (RT) accessories.
Past collaboration with the NSHA has allowed Adaptiiv to conduct research and development into refining its software platform. Now, the two organizations will work toward developing a deep understanding of the entire end-to-end clinical workflow to further incorporate innovative treatment techniques into NSHA’s existing processes, enhance the traditional RT workflow, and develop a playbook to integrate Adaptiiv’s technology on a broader scale across the entire industry.
“Adaptiiv provides the health authority with the ability to design and create patient-specific accessories quickly and accurately to improve both treatment delivery and the patient experience. Our solution integrates directly with the clinically-commissioned treatment planning system (TPS), allowing clinicians at the NSHA to perform dose and plan verification in the TPS prior to treatment which reduces any risk of not delivering the precise plan that was designed for the patient. We are excited to continue working with the NSHA to deepen our understanding of their clinical workflow, further integrate our 3D printing software solution to maximize workflow efficiencies, and ultimately become the definitive standard of care,” says Adaptiiv CEO, Peter Hickey.
About the Health Challenge
To further drive innovation in the MedTech space, Volta, Nova Scotia Health Authority, BioNova, QEII Foundation, and the Atlantic Canada Opportunities Agency, have formed a strategic partnership to present the Health Challenge, a series of five pitch events focusing on specific health care priorities. MedTech companies participating in the competition present their technologies that aim to solve various priorities pre-determined by the Nova Scotia Health Authority.
Headquartered in Halifax, Nova Scotia, Canada, Adaptiiv Medical Technologies Inc. is shaping the future of patient-specific healthcare through innovation and collaboration with industry leaders throughout the world. With FDA 510(k) clearance and a CE Mark, Adaptiiv offers a regulatory cleared software solution that has been fully validated to create custom 3D printed radiotherapy accessories. The company’s solution is currently used in a clinical setting by clients in 14 countries.